Quaternary Nanobomb Triggered Ferroptosis and Pyroptosis Enhance Immunogenicity and Immunotherapy of Triple Negative Breast Cancer
- PMID: 40955829
- DOI: 10.1002/smll.202508608
Quaternary Nanobomb Triggered Ferroptosis and Pyroptosis Enhance Immunogenicity and Immunotherapy of Triple Negative Breast Cancer
Abstract
Reversing immunosuppressive "cold" tumor into immunoresponsive "hot" tumor is the principle for immunotherapy of immunosuppressive tumors, such as triple-negative breast cancer (TNBC). In this study, the "Quaternary Nanobomb" of MnO2-shelled Chlorin e6 (Ce6), Polydopamine (PDA), Arginine (Arg), and CO2 is prepared, namely BCPA-CO2@MnO2. In the weakly acidic tumor microenvironment (TME) or the lysosome of TNBC cells (4T1 cell line), MnO2 is rapidly degraded to Mn2+, while CO2 and the large number of guanidine-mediated proton sponge effects (PSE) accelerate the "explosive release" of Ce6 and PDA. The result demonstrates that the BCPA-CO2@MnO2 disrupts intracellular ion homeostasis and exerts glutathione oxidase (GSH-Ox), catalase (CAT), and peroxidase-like activities, thereby accelerating the process of ferroptosis in 4T1 cells. Under dual near-infrared (NIR) irradiation (660 and 808 nm), the pyroptosis and immunogenic cell death (ICD) are effectively triggered by the nascent reactive oxygen species (ROS), reactive nitrogen species (RNS), and thermal effects. Ferroptosis, pyroptosis, Mn2+, and ICD-mediated damage-associated molecular patterns (DAMPs) release synergistically activate the cGAS-STING pathway, innate/adaptive immunity, thereby boosting TNBC immunogenicity and immune memory to enhance immunotherapy efficacy.
Keywords: cGAS‐STING pathway; ferroptosis; immunogenicity; proton sponge effect (PSE); pyroptosis.
© 2025 Wiley‐VCH GmbH.
References
-
- M. Manjunath, B. Choudhary, Oncol. Lett. 2021, 22, 512.
-
- C. Zhang, S. Wang, X. Lu, W. Zhong, Y. Tang, W. Huang, F. Wu, X. Wang, W. Wei, H. Tang, Research 2024, 7, 0472.
-
- F. Borri, A. Granaglia, Semin. Cancer Biol. 2021, 72, 136.
-
- X. Ou, Y. Tan, J. Xie, J. Yuan, X. Deng, R. Shao, C. Song, X. Cao, X. Xie, R. He, Y. Li, H. Tang, Drug Resist Update 2024, 73, 101063.
-
- X. Kong, J. Zhang, S. Chen, X. Wang, Q. Xi, H. Shen, R. Zhang, Cancer Biol. Med. 2024, 22, 20240055.
Grants and funding
- 32470999 82274530 62371293/National Natural Science Foundation of China
- 2023YFD1802602-2/National Key Research and Development Project of China
- 22N31900400/Nature Scientific and Technology Foundation of Shanghai
- 2024-XK-52/Key Discipline of Traditional Chinese Medicine in Zhejiang Province: Integrated Traditional Chinese and Western Medicine Clinical Practice (Proctology)
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous